Copyright Reports & Markets. All rights reserved.

Global Cancer Biomarkers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Cancer Biomarkers Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Protein Biomarkers
      • 1.2.2 Genetic Biomarkers
      • 1.2.3 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Breast Cancer
      • 1.3.2 Lung Cancer
      • 1.3.3 Colorectal Cancer
      • 1.3.4 Melanoma
      • 1.3.5 Blood Cancer
      • 1.3.6 Prostate Cancer
      • 1.3.7 Ovarian Cancer
      • 1.3.8 Stomach Cancer
      • 1.3.9 Liver Cancer
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Business Overview
      • 2.1.2 Cancer Biomarkers Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbott Laboratories Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Thermo Fisher Scientific Inc.
      • 2.2.1 Business Overview
      • 2.2.2 Cancer Biomarkers Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Thermo Fisher Scientific Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 F. Hoffmann-La Roche Ltd
      • 2.3.1 Business Overview
      • 2.3.2 Cancer Biomarkers Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Illumina,Inc.
      • 2.4.1 Business Overview
      • 2.4.2 Cancer Biomarkers Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Illumina,Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Agilent Technologies
      • 2.5.1 Business Overview
      • 2.5.2 Cancer Biomarkers Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Agilent Technologies Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Qiagen NV
      • 2.6.1 Business Overview
      • 2.6.2 Cancer Biomarkers Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Qiagen NV Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Merck & Co., Inc.
      • 2.7.1 Business Overview
      • 2.7.2 Cancer Biomarkers Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Merck & Co., Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Hologic,Inc.
      • 2.8.1 Business Overview
      • 2.8.2 Cancer Biomarkers Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Hologic,Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Novartis AG
      • 2.9.1 Business Overview
      • 2.9.2 Cancer Biomarkers Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Novartis AG Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 BioMerieux SA
      • 2.10.1 Business Overview
      • 2.10.2 Cancer Biomarkers Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 BioMerieux SA Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Genomic Health, Inc.
      • 2.11.1 Business Overview
      • 2.11.2 Cancer Biomarkers Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Genomic Health, Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Affymetrix Inc.
      • 2.12.1 Business Overview
      • 2.12.2 Cancer Biomarkers Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Affymetrix Inc. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Roche Diagnostics Ltd.
      • 2.13.1 Business Overview
      • 2.13.2 Cancer Biomarkers Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Roche Diagnostics Ltd. Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Cancer Biomarkers Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Cancer Biomarkers Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Cancer Biomarkers Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Cancer Biomarkers Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Cancer Biomarkers Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Cancer Biomarkers Market Analysis by Regions

    • 4.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Cancer Biomarkers Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Cancer Biomarkers Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 4.3 Europe Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 4.5 South America Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Cancer Biomarkers Sales and Growth Rate (2014-2019)

    5 North America Cancer Biomarkers by Country

    • 5.1 North America Cancer Biomarkers Sales, Revenue and Market Share by Country
      • 5.1.1 North America Cancer Biomarkers Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Cancer Biomarkers Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 5.3 Canada Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Cancer Biomarkers Sales and Growth Rate (2014-2019)

    6 Europe Cancer Biomarkers by Country

    • 6.1 Europe Cancer Biomarkers Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Cancer Biomarkers Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Cancer Biomarkers Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 6.3 UK Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 6.4 France Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 6.5 Russia Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 6.6 Italy Cancer Biomarkers Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Cancer Biomarkers by Country

    • 7.1 Asia-Pacific Cancer Biomarkers Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Cancer Biomarkers Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Cancer Biomarkers Revenue and Market Share by Country (2014-2019)
    • 7.2 China Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 7.3 Japan Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 7.4 Korea Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 7.5 India Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Cancer Biomarkers Sales and Growth Rate (2014-2019)

    8 South America Cancer Biomarkers by Country

    • 8.1 South America Cancer Biomarkers Sales, Revenue and Market Share by Country
      • 8.1.1 South America Cancer Biomarkers Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Cancer Biomarkers Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Cancer Biomarkers Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Cancer Biomarkers by Countries

    • 9.1 Middle East and Africa Cancer Biomarkers Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Cancer Biomarkers Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Cancer Biomarkers Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Cancer Biomarkers Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Cancer Biomarkers Sales and Growth Rate (2014-2019)

    10 Global Cancer Biomarkers Market Segment by Type

    • 10.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Cancer Biomarkers Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Cancer Biomarkers Revenue and Market Share by Type (2014-2019)
    • 10.2 Protein Biomarkers Sales Growth and Price
      • 10.2.1 Global Protein Biomarkers Sales Growth (2014-2019)
      • 10.2.2 Global Protein Biomarkers Price (2014-2019)
    • 10.3 Genetic Biomarkers Sales Growth and Price
      • 10.3.1 Global Genetic Biomarkers Sales Growth (2014-2019)
      • 10.3.2 Global Genetic Biomarkers Price (2014-2019)
    • 10.4 Others Sales Growth and Price
      • 10.4.1 Global Others Sales Growth (2014-2019)
      • 10.4.2 Global Others Price (2014-2019)

    11 Global Cancer Biomarkers Market Segment by Application

    • 11.1 Global Cancer Biomarkers Sales Market Share by Application (2014-2019)
    • 11.2 Breast Cancer Sales Growth (2014-2019)
    • 11.3 Lung Cancer Sales Growth (2014-2019)
    • 11.4 Colorectal Cancer Sales Growth (2014-2019)
    • 11.5 Melanoma Sales Growth (2014-2019)
    • 11.6 Blood Cancer Sales Growth (2014-2019)
    • 11.7 Prostate Cancer Sales Growth (2014-2019)
    • 11.8 Ovarian Cancer Sales Growth (2014-2019)
    • 11.9 Stomach Cancer Sales Growth (2014-2019)
    • 11.10 Liver Cancer Sales Growth (2014-2019)

    12 Cancer Biomarkers Market Forecast (2019-2024)

    • 12.1 Global Cancer Biomarkers Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Cancer Biomarkers Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Cancer Biomarkers Market Forecast (2019-2024)
      • 12.2.2 Europe Cancer Biomarkers Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Cancer Biomarkers Market Forecast (2019-2024)
      • 12.2.4 South America Cancer Biomarkers Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Cancer Biomarkers Market Forecast (2019-2024)
    • 12.3 Cancer Biomarkers Market Forecast by Type (2019-2024)
      • 12.3.1 Global Cancer Biomarkers Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Cancer Biomarkers Market Share Forecast by Type (2019-2024)
    • 12.4 Cancer Biomarkers Market Forecast by Application (2019-2024)
      • 12.4.1 Global Cancer Biomarkers Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Cancer Biomarkers Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Cancer Biomarkers is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Cancer Biomarkers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Abbott Laboratories
      Thermo Fisher Scientific Inc.
      F. Hoffmann-La Roche Ltd
      Illumina,Inc.
      Agilent Technologies
      Qiagen NV
      Merck & Co., Inc.
      Hologic,Inc.
      Novartis AG
      BioMerieux SA
      Genomic Health, Inc.
      Affymetrix Inc.
      Roche Diagnostics Ltd.

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Protein Biomarkers
      Genetic Biomarkers
      Others

      Market Segment by Applications, can be divided into
      Breast Cancer
      Lung Cancer
      Colorectal Cancer
      Melanoma
      Blood Cancer
      Prostate Cancer
      Ovarian Cancer
      Stomach Cancer
      Liver Cancer

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Cancer Biomarkers product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Cancer Biomarkers, with price, sales, revenue and global market share of Cancer Biomarkers in 2017 and 2018.
      Chapter 3, the Cancer Biomarkers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Cancer Biomarkers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Cancer Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Cancer Biomarkers sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now